Results 231 to 240 of about 1,640,336 (314)
[Retracted] MicroRNA‑302a targets GAB2 to suppress cell proliferation, migration and invasion of glioma. [PDF]
Ma J +8 more
europepmc +1 more source
Exercise as a Standard of Care in Oncology Rehabilitation: Harsh Reality Versus Aspiration
Gerwyn Morris
openalex +1 more source
The study reveals that RRP9 is abnormally highly expressed in ESCC tissues and is closely associated with poor prognosis in patients. Furthermore, it is found that RRP9 promotes ESCC progression through enhancing the E2F1‐mediated transcriptional regulation of CDK1.
Gang He +14 more
wiley +1 more source
Correction to: Final results of the Choroid Plexus Tumor Study CPT-SIOP-2000. [PDF]
Wolff JE +10 more
europepmc +1 more source
Joint modeling of time to recurrence and cancer stage at recurrence in oncology trials
Olga Marchenko +4 more
openalex +2 more sources
Amide local anesthetics (LA) affect tumor burden in various preclinical studies, possibly via their anti‐inflammatory properties. However, a translation into clinical evidence is still lacking. The current study demonstrates that LA ‐ even at clinically relevant concentrations – exert a strong anti‐tumoral effect in a complex ex vivo model patient ...
Juliane Krömer +8 more
wiley +1 more source
Temporal evolution of large language models (LLMs) in oncology. [PDF]
Qiu Z +19 more
europepmc +1 more source
Correction to ‘Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors’
Molecular Oncology, EarlyView.
wiley +1 more source
The review provides a critical up‐to‐date overview of the current landscape of human in vitro models for fatty liver disease, including spheroids, organoids, organ‐on‐a‐chip systems, bioprinted liver constructs and precision‐cut liver slices. Their utility for faithfully modeling different stages of MASLD and MASH are evaluated and their compatibility ...
Sonia Youhanna +6 more
wiley +1 more source
RETRACTION: LncRNA NKILA Promotes Epithelial-Mesenchymal Transition of Liver Cancer Cells by Targeting miR-485-5p. [PDF]
Oncology JO.
europepmc +1 more source

